Search results
Showing 6361 to 6375 of 9055 results
Recommendation ID IPG619/1 Question Research on the safety and efficacy of superior capsular augmentation for massive rotator cuff tears
Recommendation ID NG52/2 Question Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people
Recommendation ID NG52/1 Question Baseline FDG-PET-CT imaging for people with diffuse large B-cell lymphoma stage II or above:- In people
Recommendation ID NG52/3 Question Radiotherapy in first-line treatment of diffuse large B-cell lymphoma:- In people presenting with diffuse
Recommendation ID NG50/8 Question Acute hepatic encephalopathy:- In people with cirrhosis and an acute episode of hepatic encephalopathy
Our evidence standards framework for digital care technologies
NICE has been commissioned by the Department of Health and Social Care and NHS England to adapt the evidence standards framework for digital health technologies to support evidence-based decision making for digital care technologies used in adult social care.
A consultation has begun on draft guidance recommending 4 specialist liver preservation machines for routine NHS use, which could help more of the 600 people in England waiting for a life-saving transplant.
New functionality for online collaboration on consultations, enables groups or organisations to submit a joined-up response.
Neonatal infection guidance updated to allow home antibiotic treatment for some babies
We’ve recommended that newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home if they are doing well and responding to treatment.
Home News Podcasts Treating babies at home with oral antibiotics Podcasts 27 May 2026 Listen About this episode In this episode we discuss
NICE issues new guidance on 'artificial pancreas' technology for pregnant women with type 1 diabetes
Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published today by NICE.
Why flexibility is built into everything we do at NICE Advice
No two products are the same, so no two NICE Advice projects should be either. Andrew Walsh explains how NICE Advice adapts its services to fit your situation.
First new NHS treatment in over 20 years recommended for women with resistant ovarian cancer
The treatment uses a targeted therapy that seeks out a specific protein found on the surface of cancer cells and delivers a cancer-killing medicine directly to them.
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
Learn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.